Back
Johnson & Johnson 10K Form
Buy
57
JNJ
Johnson & Johnson
Last Price:
160.00
Seasonality Move:
1.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-07-29 | 10Q | JNJ/Johnson & Johnson Quarterly |
2021-04-30 | 10Q | JNJ/Johnson & Johnson Quarterly |
2021-02-22 | 10K | JNJ/Johnson & Johnson Annual |
2020-10-23 | 10Q | JNJ/Johnson & Johnson Quarterly |
2020-07-24 | 10Q | JNJ/Johnson & Johnson Quarterly |
2020-04-29 | 10Q | JNJ/Johnson & Johnson Quarterly |
Receive JNJ News And Ratings
See the #1 stock for the next 7 days that we like better than JNJ
JNJ Financial Statistics
Sales & Book Value
Annual Sales: | $94.94B |
---|---|
Cash Flow: | $2.39B |
Price / Cash Flow: | 26.13 |
Annual Sales: | $27.12 |
Price / Book: | 5.87 |
Profitability
EPS (TTM): | 4.78000 |
---|---|
Net Income (TTM): | $12.72B |
Gross Margin: | $63.85B |
Return on Equity: | 17.04% |
Return on Assets: | 6.96% |
Johnson & Johnson Earnings Forecast
Key Johnson & Johnson Financial Ratios
- The Gross Profit Margin over the past 39 years for JNJ is 67.26%.
- The Selling, General & Administrative Expenses for JNJ have been equal to 26.08% of Gross Profit Margin.
- The Research & Development expenses have been 16.21% of Revenue.
- The Interest Expense is 1.54% of Operating Income.
- The Net Earning history of JNJ is 18.90% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 28 years.
Johnson & Johnson Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Drug Manufacturers - General |
Sector: | Healthcare |
Current Symbol: | JNJ |
CUSIP: | 478160 |
Website: | jnj.com |
Debt
Debt-to-Equity Ratio: | 0.75 |
---|---|
Current Ratio: | 1.07 |
Quick Ratio: | 0.68 |
Price-to-Earnings
Trailing P/E Ratio: | 23.77 |
---|---|
Forward P/E Ratio: | 14.54 |
JNJ Technical Analysis vs Fundamental Analysis
Buy
57
Johnson & Johnson (JNJ)
is a Buy
Is Johnson & Johnson a Buy or a Sell?
-
Johnson & Johnson stock is rated a Buy
The current Johnson & Johnson [JNJ] share price is $160.01. The Score for JNJ is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.